Autem Therapeutics Alternatives & Competitors
12 companies similar to Autem Therapeutics — EM-Powering Cancer Care
Companies similar to Autem Therapeutics
Alpheus Medical, Inc
Changing the way cancer is treated.
Cognito Therapeutics, Inc.
Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerati...
Soricimed Biopharma Inc.
Dedicated to developing effective and novel targeted treatments for cancer.
Impulse Dynamics
A cardiac medical device company determined to improve the lives of heart failure patients...
Rival Readout
Competing with Autem Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Kintara Therapeutics, Inc. NASDAQ: KTRA
Seeking New Horizons for Cancer Patients
Arcellx
Arcellx is a clinical-stage biotechnology company based in Redwood City, California
Gracell Biotechnologies
A Member of the AstraZeneca Group
ImmunoGen
Focusing on core therapeutic areas such as immunology, oncology, neuroscience, eye care, a...
Kite Pharma
At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.
Stembio Cell and Tissue Technologies Inc.
Our purpose is to build a leading, focused ATMPs company powered by advanced therapy platf...
ARTBIO
Channeling Energy. Changing Lives.
Geneseeq Technology Inc.
Cancer: a word, not a sentence!
About Autem Therapeutics
Autem Therapeutics, operating under the slogan "EM-Powering Cancer Care," is a pioneering company in the Biotechnology and Health Care sectors. Based in Hanover, NH, USA, and founded in 2017, this privately held firm is at the forefront of developing a novel, non-invasive treatment platform targeting solid tumors like...
Cancer treatment using Autem Therapy, Supply of AutEMsys™ devices, Research and development in biotechnology
Cancer Patients, Healthcare Providers, Remote Medical Facilities
Oncology Therapy, Bioelectric Treatment, Non-invasive Treatment, Non-toxic Therapy, HCC, Liver Cancer, Solid Tumor Cancers, FDA Breakthrough Designation, AutEMsys™ Therapy, Electromagnetic Frequencies, Clinical Feasibility Studies, FDA Investigational Device Exemption (IDE), Pivotal Clinical Trials, Cancer Treatment Innovation, Medical Device Development
B2B2C, B2B
Product Sales, Usage Based, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Autem Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Autem Therapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.